•Risk of Infections With Infliximab vs Adalimumab Among Children With Inflammatory Bowel Disease
•Patient preferences toward the attributes of treatment used for inflammatory bowel disease in Saudi Arabia: Subgroup analysis from an international multicenter discrete choice experiment
•IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery
•Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn's disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 years
•Efficacy and safety of ozanimod in Japanese patients with moderately to severely active ulcerative colitis naive to immunomodulators or advanced therapies: post hoc analysis of the phase 2/3 J-True North study
